Global Companion Diagnostics Market Research Report 2026(Status and Outlook)
A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product?s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient?s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient?s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on. These tests aim at providing insights into the patient?s likely response pattern to a particular therapy, thereby enabling optimization of appropriate dosing concentrations and course of administration. The increasing importance of personalized medicine and commercialization of targeted therapeutics have driven the demand for companion diagnostics, which in turn is projected to observe a rise in trend of adoption by patients as well as health care service providers.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Companion Diagnostics market size was estimated at USD 5106.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics market.
Global Companion Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics Market
Overview of the regional outlook of the Companion Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Companion Diagnostics market size was estimated at USD 5106.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 13.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Companion Diagnostics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Companion Diagnostics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Companion Diagnostics market.
Global Companion Diagnostics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Life Technologies
GE Healthcare
Agendia
Qiagen
Genomic Health
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Applied Proteomics
Market Segmentation (by Type)
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market Segmentation (by Application)
Hospitals
Pharmaceutical Companies
Laboratories
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Companion Diagnostics Market
Overview of the regional outlook of the Companion Diagnostics Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Companion Diagnostics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Companion Diagnostics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Companion Diagnostics Product Life Cycle
3.3 Global Companion Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Companion Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Companion Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Companion Diagnostics Market Competitive Situation and Trends
3.8.1 Companion Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Companion Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Companion Diagnostics Market Size by Type (2020-2025)
6.4 Global Companion Diagnostics Price by Type (2020-2025)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2020-2025)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
8 COMPANION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 Global Companion Diagnostics Market Size by Region
8.2.1 Global Companion Diagnostics Market Size by Region
8.2.2 Global Companion Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Companion Diagnostics Sales by Country
8.3.2 North America Companion Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Companion Diagnostics Sales by Country
8.4.2 Europe Companion Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Companion Diagnostics Sales by Region
8.5.2 Asia Pacific Companion Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Companion Diagnostics Sales by Country
8.6.2 South America Companion Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Companion Diagnostics Sales by Region
8.7.2 Middle East and Africa Companion Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COMPANION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics by Region(2020-2025)
9.2 Global Companion Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Companion Diagnostics Production
9.4.1 North America Companion Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Companion Diagnostics Production
9.5.1 Europe Companion Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Companion Diagnostics Production (2020-2025)
9.6.1 Japan Companion Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Companion Diagnostics Production (2020-2025)
9.7.1 China Companion Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Basic Information
10.1.2 Roche Holdings Companion Diagnostics Product Overview
10.1.3 Roche Holdings Companion Diagnostics Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Basic Information
10.2.2 Abbott Laboratories Companion Diagnostics Product Overview
10.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
10.3.4 Thermo Fisher Scientific Business Overview
10.3.5 Thermo Fisher Scientific SWOT Analysis
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Basic Information
10.4.2 Agilent Technologies Companion Diagnostics Product Overview
10.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Life Technologies
10.5.1 Life Technologies Basic Information
10.5.2 Life Technologies Companion Diagnostics Product Overview
10.5.3 Life Technologies Companion Diagnostics Product Market Performance
10.5.4 Life Technologies Business Overview
10.5.5 Life Technologies Recent Developments
10.6 GE Healthcare
10.6.1 GE Healthcare Basic Information
10.6.2 GE Healthcare Companion Diagnostics Product Overview
10.6.3 GE Healthcare Companion Diagnostics Product Market Performance
10.6.4 GE Healthcare Business Overview
10.6.5 GE Healthcare Recent Developments
10.7 Agendia
10.7.1 Agendia Basic Information
10.7.2 Agendia Companion Diagnostics Product Overview
10.7.3 Agendia Companion Diagnostics Product Market Performance
10.7.4 Agendia Business Overview
10.7.5 Agendia Recent Developments
10.8 Qiagen
10.8.1 Qiagen Basic Information
10.8.2 Qiagen Companion Diagnostics Product Overview
10.8.3 Qiagen Companion Diagnostics Product Market Performance
10.8.4 Qiagen Business Overview
10.8.5 Qiagen Recent Developments
10.9 Genomic Health
10.9.1 Genomic Health Basic Information
10.9.2 Genomic Health Companion Diagnostics Product Overview
10.9.3 Genomic Health Companion Diagnostics Product Market Performance
10.9.4 Genomic Health Business Overview
10.9.5 Genomic Health Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Basic Information
10.10.2 Myriad Genetics Companion Diagnostics Product Overview
10.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Basic Information
10.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
10.11.4 Advanced Cell Diagnostics Business Overview
10.11.5 Advanced Cell Diagnostics Recent Developments
10.12 Danaher
10.12.1 Danaher Basic Information
10.12.2 Danaher Companion Diagnostics Product Overview
10.12.3 Danaher Companion Diagnostics Product Market Performance
10.12.4 Danaher Business Overview
10.12.5 Danaher Recent Developments
10.13 Applied Proteomics
10.13.1 Applied Proteomics Basic Information
10.13.2 Applied Proteomics Companion Diagnostics Product Overview
10.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
10.13.4 Applied Proteomics Business Overview
10.13.5 Applied Proteomics Recent Developments
11 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics Market Size Forecast
11.2 Global Companion Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
11.2.4 South America Companion Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Companion Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2026-2035)
12.1.2 Global Companion Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Companion Diagnostics by Type (2026-2035)
12.2 Global Companion Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Companion Diagnostics
1.2 Key Market Segments
1.2.1 Companion Diagnostics Segment by Type
1.2.2 Companion Diagnostics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 COMPANION DIAGNOSTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Companion Diagnostics Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Companion Diagnostics Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 COMPANION DIAGNOSTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Companion Diagnostics Product Life Cycle
3.3 Global Companion Diagnostics Sales by Manufacturers (2020-2025)
3.4 Global Companion Diagnostics Revenue Market Share by Manufacturers (2020-2025)
3.5 Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Companion Diagnostics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Companion Diagnostics Market Competitive Situation and Trends
3.8.1 Companion Diagnostics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Companion Diagnostics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 COMPANION DIAGNOSTICS INDUSTRY CHAIN ANALYSIS
4.1 Companion Diagnostics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF COMPANION DIAGNOSTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Companion Diagnostics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Companion Diagnostics Market
5.7 ESG Ratings of Leading Companies
6 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostics Sales Market Share by Type (2020-2025)
6.3 Global Companion Diagnostics Market Size by Type (2020-2025)
6.4 Global Companion Diagnostics Price by Type (2020-2025)
7 COMPANION DIAGNOSTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostics Market Sales by Application (2020-2025)
7.3 Global Companion Diagnostics Market Size (M USD) by Application (2020-2025)
7.4 Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
8 COMPANION DIAGNOSTICS MARKET SALES BY REGION
8.1 Global Companion Diagnostics Sales by Region
8.1.1 Global Companion Diagnostics Sales by Region
8.1.2 Global Companion Diagnostics Sales Market Share by Region
8.2 Global Companion Diagnostics Market Size by Region
8.2.1 Global Companion Diagnostics Market Size by Region
8.2.2 Global Companion Diagnostics Market Size by Region
8.3 North America
8.3.1 North America Companion Diagnostics Sales by Country
8.3.2 North America Companion Diagnostics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Companion Diagnostics Sales by Country
8.4.2 Europe Companion Diagnostics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Companion Diagnostics Sales by Region
8.5.2 Asia Pacific Companion Diagnostics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Companion Diagnostics Sales by Country
8.6.2 South America Companion Diagnostics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Companion Diagnostics Sales by Region
8.7.2 Middle East and Africa Companion Diagnostics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 COMPANION DIAGNOSTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Companion Diagnostics by Region(2020-2025)
9.2 Global Companion Diagnostics Revenue Market Share by Region (2020-2025)
9.3 Global Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Companion Diagnostics Production
9.4.1 North America Companion Diagnostics Production Growth Rate (2020-2025)
9.4.2 North America Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Companion Diagnostics Production
9.5.1 Europe Companion Diagnostics Production Growth Rate (2020-2025)
9.5.2 Europe Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Companion Diagnostics Production (2020-2025)
9.6.1 Japan Companion Diagnostics Production Growth Rate (2020-2025)
9.6.2 Japan Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Companion Diagnostics Production (2020-2025)
9.7.1 China Companion Diagnostics Production Growth Rate (2020-2025)
9.7.2 China Companion Diagnostics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche Holdings
10.1.1 Roche Holdings Basic Information
10.1.2 Roche Holdings Companion Diagnostics Product Overview
10.1.3 Roche Holdings Companion Diagnostics Product Market Performance
10.1.4 Roche Holdings Business Overview
10.1.5 Roche Holdings SWOT Analysis
10.1.6 Roche Holdings Recent Developments
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Basic Information
10.2.2 Abbott Laboratories Companion Diagnostics Product Overview
10.2.3 Abbott Laboratories Companion Diagnostics Product Market Performance
10.2.4 Abbott Laboratories Business Overview
10.2.5 Abbott Laboratories SWOT Analysis
10.2.6 Abbott Laboratories Recent Developments
10.3 Thermo Fisher Scientific
10.3.1 Thermo Fisher Scientific Basic Information
10.3.2 Thermo Fisher Scientific Companion Diagnostics Product Overview
10.3.3 Thermo Fisher Scientific Companion Diagnostics Product Market Performance
10.3.4 Thermo Fisher Scientific Business Overview
10.3.5 Thermo Fisher Scientific SWOT Analysis
10.3.6 Thermo Fisher Scientific Recent Developments
10.4 Agilent Technologies
10.4.1 Agilent Technologies Basic Information
10.4.2 Agilent Technologies Companion Diagnostics Product Overview
10.4.3 Agilent Technologies Companion Diagnostics Product Market Performance
10.4.4 Agilent Technologies Business Overview
10.4.5 Agilent Technologies Recent Developments
10.5 Life Technologies
10.5.1 Life Technologies Basic Information
10.5.2 Life Technologies Companion Diagnostics Product Overview
10.5.3 Life Technologies Companion Diagnostics Product Market Performance
10.5.4 Life Technologies Business Overview
10.5.5 Life Technologies Recent Developments
10.6 GE Healthcare
10.6.1 GE Healthcare Basic Information
10.6.2 GE Healthcare Companion Diagnostics Product Overview
10.6.3 GE Healthcare Companion Diagnostics Product Market Performance
10.6.4 GE Healthcare Business Overview
10.6.5 GE Healthcare Recent Developments
10.7 Agendia
10.7.1 Agendia Basic Information
10.7.2 Agendia Companion Diagnostics Product Overview
10.7.3 Agendia Companion Diagnostics Product Market Performance
10.7.4 Agendia Business Overview
10.7.5 Agendia Recent Developments
10.8 Qiagen
10.8.1 Qiagen Basic Information
10.8.2 Qiagen Companion Diagnostics Product Overview
10.8.3 Qiagen Companion Diagnostics Product Market Performance
10.8.4 Qiagen Business Overview
10.8.5 Qiagen Recent Developments
10.9 Genomic Health
10.9.1 Genomic Health Basic Information
10.9.2 Genomic Health Companion Diagnostics Product Overview
10.9.3 Genomic Health Companion Diagnostics Product Market Performance
10.9.4 Genomic Health Business Overview
10.9.5 Genomic Health Recent Developments
10.10 Myriad Genetics
10.10.1 Myriad Genetics Basic Information
10.10.2 Myriad Genetics Companion Diagnostics Product Overview
10.10.3 Myriad Genetics Companion Diagnostics Product Market Performance
10.10.4 Myriad Genetics Business Overview
10.10.5 Myriad Genetics Recent Developments
10.11 Advanced Cell Diagnostics
10.11.1 Advanced Cell Diagnostics Basic Information
10.11.2 Advanced Cell Diagnostics Companion Diagnostics Product Overview
10.11.3 Advanced Cell Diagnostics Companion Diagnostics Product Market Performance
10.11.4 Advanced Cell Diagnostics Business Overview
10.11.5 Advanced Cell Diagnostics Recent Developments
10.12 Danaher
10.12.1 Danaher Basic Information
10.12.2 Danaher Companion Diagnostics Product Overview
10.12.3 Danaher Companion Diagnostics Product Market Performance
10.12.4 Danaher Business Overview
10.12.5 Danaher Recent Developments
10.13 Applied Proteomics
10.13.1 Applied Proteomics Basic Information
10.13.2 Applied Proteomics Companion Diagnostics Product Overview
10.13.3 Applied Proteomics Companion Diagnostics Product Market Performance
10.13.4 Applied Proteomics Business Overview
10.13.5 Applied Proteomics Recent Developments
11 COMPANION DIAGNOSTICS MARKET FORECAST BY REGION
11.1 Global Companion Diagnostics Market Size Forecast
11.2 Global Companion Diagnostics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Companion Diagnostics Market Size Forecast by Country
11.2.3 Asia Pacific Companion Diagnostics Market Size Forecast by Region
11.2.4 South America Companion Diagnostics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Companion Diagnostics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Companion Diagnostics Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Companion Diagnostics by Type (2026-2035)
12.1.2 Global Companion Diagnostics Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Companion Diagnostics by Type (2026-2035)
12.2 Global Companion Diagnostics Market Forecast by Application (2026-2035)
12.2.1 Global Companion Diagnostics Sales (K Units) Forecast by Application
12.2.2 Global Companion Diagnostics Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Companion Diagnostics Market Size by Type (M USD)
Table 4. Global Companion Diagnostics Market Size by Application
Table 5. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Companion Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Companion Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Companion Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2025)
Table 11. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Companion Diagnostics Sales by Type (K Units)
Table 27. Global Companion Diagnostics Market Size by Type (M USD)
Table 28. Global Companion Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Companion Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Companion Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Companion Diagnostics Market Share by Type (2020-2025)
Table 32. Global Companion Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Companion Diagnostics Sales (K Units) by Application
Table 34. Global Companion Diagnostics Market Size by Application
Table 35. Global Companion Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Companion Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Companion Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Companion Diagnostics Market Share by Application (2020-2025)
Table 39. Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Companion Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Companion Diagnostics Market Size by Region (2020-2025)
Table 44. North America Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Companion Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Companion Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Companion Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Holdings Basic Information
Table 63. Roche Holdings Companion Diagnostics Product Overview
Table 64. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Holdings Business Overview
Table 66. Roche Holdings SWOT Analysis
Table 67. Roche Holdings Recent Developments
Table 68. Abbott Laboratories Basic Information
Table 69. Abbott Laboratories Companion Diagnostics Product Overview
Table 70. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Laboratories Business Overview
Table 72. Abbott Laboratories SWOT Analysis
Table 73. Abbott Laboratories Recent Developments
Table 74. Thermo Fisher Scientific Basic Information
Table 75. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 76. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific SWOT Analysis
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. Agilent Technologies Basic Information
Table 81. Agilent Technologies Companion Diagnostics Product Overview
Table 82. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Recent Developments
Table 85. Life Technologies Basic Information
Table 86. Life Technologies Companion Diagnostics Product Overview
Table 87. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Life Technologies Business Overview
Table 89. Life Technologies Recent Developments
Table 90. GE Healthcare Basic Information
Table 91. GE Healthcare Companion Diagnostics Product Overview
Table 92. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GE Healthcare Business Overview
Table 94. GE Healthcare Recent Developments
Table 95. Agendia Basic Information
Table 96. Agendia Companion Diagnostics Product Overview
Table 97. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Agendia Business Overview
Table 99. Agendia Recent Developments
Table 100. Qiagen Basic Information
Table 101. Qiagen Companion Diagnostics Product Overview
Table 102. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Qiagen Business Overview
Table 104. Qiagen Recent Developments
Table 105. Genomic Health Basic Information
Table 106. Genomic Health Companion Diagnostics Product Overview
Table 107. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Genomic Health Business Overview
Table 109. Genomic Health Recent Developments
Table 110. Myriad Genetics Basic Information
Table 111. Myriad Genetics Companion Diagnostics Product Overview
Table 112. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Myriad Genetics Business Overview
Table 114. Myriad Genetics Recent Developments
Table 115. Advanced Cell Diagnostics Basic Information
Table 116. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 117. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Advanced Cell Diagnostics Business Overview
Table 119. Advanced Cell Diagnostics Recent Developments
Table 120. Danaher Basic Information
Table 121. Danaher Companion Diagnostics Product Overview
Table 122. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Danaher Business Overview
Table 124. Danaher Recent Developments
Table 125. Applied Proteomics Basic Information
Table 126. Applied Proteomics Companion Diagnostics Product Overview
Table 127. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Applied Proteomics Business Overview
Table 129. Applied Proteomics Recent Developments
Table 130. Global Companion Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Companion Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Companion Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Companion Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Companion Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Companion Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Companion Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Companion Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Companion Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Companion Diagnostics Market Size by Type (M USD)
Table 4. Global Companion Diagnostics Market Size by Application
Table 5. Companion Diagnostics Market Size Comparison by Region (M USD)
Table 6. Global Companion Diagnostics Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Companion Diagnostics Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Companion Diagnostics Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Companion Diagnostics Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics as of 2025)
Table 11. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Companion Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Companion Diagnostics Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Companion Diagnostics Sales by Type (K Units)
Table 27. Global Companion Diagnostics Market Size by Type (M USD)
Table 28. Global Companion Diagnostics Sales (K Units) by Type (2020-2025)
Table 29. Global Companion Diagnostics Sales Market Share by Type (2020-2025)
Table 30. Global Companion Diagnostics Market Size (M USD) by Type (2020-2025)
Table 31. Global Companion Diagnostics Market Share by Type (2020-2025)
Table 32. Global Companion Diagnostics Price (USD/Unit) by Type (2020-2025)
Table 33. Global Companion Diagnostics Sales (K Units) by Application
Table 34. Global Companion Diagnostics Market Size by Application
Table 35. Global Companion Diagnostics Sales by Application (2020-2025) & (K Units)
Table 36. Global Companion Diagnostics Sales Market Share by Application (2020-2025)
Table 37. Global Companion Diagnostics Market Size by Application (2020-2025) & (M USD)
Table 38. Global Companion Diagnostics Market Share by Application (2020-2025)
Table 39. Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
Table 40. Global Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 41. Global Companion Diagnostics Sales Market Share by Region (2020-2025)
Table 42. Global Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 43. Global Companion Diagnostics Market Size by Region (2020-2025)
Table 44. North America Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 45. North America Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 47. Europe Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 50. South America Companion Diagnostics Sales by Country (2020-2025) & (K Units)
Table 51. South America Companion Diagnostics Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Companion Diagnostics Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Companion Diagnostics Market Size by Region (2020-2025) & (M USD)
Table 54. Global Companion Diagnostics Production (K Units) by Region(2020-2025)
Table 55. Global Companion Diagnostics Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Companion Diagnostics Revenue Market Share by Region (2020-2025)
Table 57. Global Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Companion Diagnostics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Roche Holdings Basic Information
Table 63. Roche Holdings Companion Diagnostics Product Overview
Table 64. Roche Holdings Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Roche Holdings Business Overview
Table 66. Roche Holdings SWOT Analysis
Table 67. Roche Holdings Recent Developments
Table 68. Abbott Laboratories Basic Information
Table 69. Abbott Laboratories Companion Diagnostics Product Overview
Table 70. Abbott Laboratories Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Abbott Laboratories Business Overview
Table 72. Abbott Laboratories SWOT Analysis
Table 73. Abbott Laboratories Recent Developments
Table 74. Thermo Fisher Scientific Basic Information
Table 75. Thermo Fisher Scientific Companion Diagnostics Product Overview
Table 76. Thermo Fisher Scientific Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific SWOT Analysis
Table 79. Thermo Fisher Scientific Recent Developments
Table 80. Agilent Technologies Basic Information
Table 81. Agilent Technologies Companion Diagnostics Product Overview
Table 82. Agilent Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Recent Developments
Table 85. Life Technologies Basic Information
Table 86. Life Technologies Companion Diagnostics Product Overview
Table 87. Life Technologies Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Life Technologies Business Overview
Table 89. Life Technologies Recent Developments
Table 90. GE Healthcare Basic Information
Table 91. GE Healthcare Companion Diagnostics Product Overview
Table 92. GE Healthcare Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. GE Healthcare Business Overview
Table 94. GE Healthcare Recent Developments
Table 95. Agendia Basic Information
Table 96. Agendia Companion Diagnostics Product Overview
Table 97. Agendia Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Agendia Business Overview
Table 99. Agendia Recent Developments
Table 100. Qiagen Basic Information
Table 101. Qiagen Companion Diagnostics Product Overview
Table 102. Qiagen Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Qiagen Business Overview
Table 104. Qiagen Recent Developments
Table 105. Genomic Health Basic Information
Table 106. Genomic Health Companion Diagnostics Product Overview
Table 107. Genomic Health Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Genomic Health Business Overview
Table 109. Genomic Health Recent Developments
Table 110. Myriad Genetics Basic Information
Table 111. Myriad Genetics Companion Diagnostics Product Overview
Table 112. Myriad Genetics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Myriad Genetics Business Overview
Table 114. Myriad Genetics Recent Developments
Table 115. Advanced Cell Diagnostics Basic Information
Table 116. Advanced Cell Diagnostics Companion Diagnostics Product Overview
Table 117. Advanced Cell Diagnostics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Advanced Cell Diagnostics Business Overview
Table 119. Advanced Cell Diagnostics Recent Developments
Table 120. Danaher Basic Information
Table 121. Danaher Companion Diagnostics Product Overview
Table 122. Danaher Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Danaher Business Overview
Table 124. Danaher Recent Developments
Table 125. Applied Proteomics Basic Information
Table 126. Applied Proteomics Companion Diagnostics Product Overview
Table 127. Applied Proteomics Companion Diagnostics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Applied Proteomics Business Overview
Table 129. Applied Proteomics Recent Developments
Table 130. Global Companion Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 131. Global Companion Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 132. North America Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 133. North America Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 134. Europe Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 135. Europe Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Asia Pacific Companion Diagnostics Sales Forecast by Region (2026-2035) & (K Units)
Table 137. Asia Pacific Companion Diagnostics Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Companion Diagnostics Sales Forecast by Country (2026-2035) & (K Units)
Table 139. South America Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Middle East and Africa Companion Diagnostics Sales Forecast by Country (2026-2035) & (Units)
Table 141. Middle East and Africa Companion Diagnostics Market Size Forecast by Country (2026-2035) & (M USD)
Table 142. Global Companion Diagnostics Sales Forecast by Type (2026-2035) & (K Units)
Table 143. Global Companion Diagnostics Market Size Forecast by Type (2026-2035) & (M USD)
Table 144. Global Companion Diagnostics Price Forecast by Type (2026-2035) & (USD/Unit)
Table 145. Global Companion Diagnostics Sales (K Units) Forecast by Application (2026-2035)
Table 146. Global Companion Diagnostics Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Companion Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Companion Diagnostics Product Life Cycle
Figure 13. Companion Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Companion Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Companion Diagnostics
Figure 19. Global Companion Diagnostics Market PEST Analysis
Figure 20. Global Companion Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Companion Diagnostics Market Share by Type
Figure 27. Sales Market Share of Companion Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Companion Diagnostics by Type in 2025
Figure 29. Market Share of Companion Diagnostics by Type (2020-2025)
Figure 30. Market Share of Companion Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Companion Diagnostics Market Share by Application
Figure 33. Global Companion Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Companion Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Companion Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Companion Diagnostics Market Share by Application in 2025
Figure 37. Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Companion Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Companion Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Companion Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Companion Diagnostics Market Size by Country in 2024
Figure 45. U.S. Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Companion Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Companion Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Companion Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Companion Diagnostics Market Size by Country in 2024
Figure 55. Germany Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Companion Diagnostics Market Size by Region in 2024
Figure 68. China Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Companion Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Companion Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Companion Diagnostics Market Size by Country in 2024
Figure 82. Brazil Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Companion Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Companion Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Companion Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Companion Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Companion Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Companion Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Companion Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Companion Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Companion Diagnostics Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Companion Diagnostics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Companion Diagnostics Market Size (M USD), 2025-2035
Figure 5. Global Companion Diagnostics Market Size (M USD) (2020-2035)
Figure 6. Global Companion Diagnostics Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Companion Diagnostics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Companion Diagnostics Product Life Cycle
Figure 13. Companion Diagnostics Sales Share by Manufacturers in 2025
Figure 14. Global Companion Diagnostics Revenue Share by Manufacturers in 2025
Figure 15. Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Companion Diagnostics Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Companion Diagnostics Revenue in 2025
Figure 18. Industry Chain Map of Companion Diagnostics
Figure 19. Global Companion Diagnostics Market PEST Analysis
Figure 20. Global Companion Diagnostics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Companion Diagnostics Market Share by Type
Figure 27. Sales Market Share of Companion Diagnostics by Type (2020-2025)
Figure 28. Sales Market Share of Companion Diagnostics by Type in 2025
Figure 29. Market Share of Companion Diagnostics by Type (2020-2025)
Figure 30. Market Share of Companion Diagnostics by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Companion Diagnostics Market Share by Application
Figure 33. Global Companion Diagnostics Sales Market Share by Application (2020-2025)
Figure 34. Global Companion Diagnostics Sales Market Share by Application in 2025
Figure 35. Global Companion Diagnostics Market Share by Application (2020-2025)
Figure 36. Global Companion Diagnostics Market Share by Application in 2025
Figure 37. Global Companion Diagnostics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Companion Diagnostics Sales Market Share by Region (2020-2025)
Figure 39. Global Companion Diagnostics Market Size by Region (2020-2025)
Figure 40. North America Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Companion Diagnostics Sales Market Share by Country in 2024
Figure 43. North America Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Companion Diagnostics Market Size by Country in 2024
Figure 45. U.S. Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Companion Diagnostics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Companion Diagnostics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Companion Diagnostics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Companion Diagnostics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Companion Diagnostics Sales Market Share by Country in 2024
Figure 53. Europe Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Companion Diagnostics Market Size by Country in 2024
Figure 55. Germany Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Companion Diagnostics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Companion Diagnostics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Companion Diagnostics Market Size by Region in 2024
Figure 68. China Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Companion Diagnostics Sales and Growth Rate (K Units)
Figure 79. South America Companion Diagnostics Sales Market Share by Country in 2024
Figure 80. South America Companion Diagnostics Market Size and Growth Rate (M USD)
Figure 81. South America Companion Diagnostics Market Size by Country in 2024
Figure 82. Brazil Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Companion Diagnostics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Companion Diagnostics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Companion Diagnostics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Companion Diagnostics Market Size by Region in 2024
Figure 92. Saudi Arabia Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Companion Diagnostics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Companion Diagnostics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Companion Diagnostics Production Market Share by Region (2020-2025)
Figure 103. North America Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Companion Diagnostics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Companion Diagnostics Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Companion Diagnostics Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Companion Diagnostics Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Companion Diagnostics Market Share Forecast by Type (2026-2035)
Figure 111. Global Companion Diagnostics Sales Forecast by Application (2026-2035)
Figure 112. Global Companion Diagnostics Market Share Forecast by Application (2026-2035)
